• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    NOV Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    4/29/25 9:00:21 AM ET
    $NOV
    Metal Fabrications
    Industrials
    Get the next $NOV alert in real time by email
    8-K
    0001021860false00010218602025-04-282025-04-28

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): April 28, 2025

     

    NOV INC.

    (Exact Name of Registrant as Specified in Charter)

     

     

    Delaware

    1-12317

    76-0475815

    (State or Other Jurisdiction

    of Incorporation)

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

     

    10353 Richmond Ave.

    Houston, Texas

    77042

    (Address of Principal Executive Offices)

    (Zip Code)

    Registrant’s Telephone Number, Including Area Code 346-223-3000

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐

    Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

    Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

    Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

     

     

     

     

    Title of each class

    Trading Symbol(s)

    Name of each exchange on which registered

    Common Stock, par value $0.01 per share

    NOV

    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


    Item 2.02 Results of Operations and Financial Condition

    On April 28, 2025, NOV Inc. issued a press release announcing earnings for the quarter ended March 31, 2025 and conference call in connection therewith. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. A presentation to accompany the conference call, which contains certain historical and forward-looking information relating to the Company (the “Presentation Materials”), has been made available on its website at www.nov.com. A copy of the Presentation Materials is attached hereto as Exhibit 99.2 and incorporated herein by reference.

     

    Cautionary Note Regarding Forward-Looking Statements

    This report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to a number of risks, uncertainties and assumptions, including the factors described in the Company’s most recent periodic reports and other documents filed with the Securities and Exchange Commission (the “SEC”), which are available free of charge at the SEC’s website at www.sec.gov or the Company’s website at www.nov.com. The Company cautions you that forward-looking statements are not guarantees of future performance and that actual results or developments may differ materially from those projected or implied in these statements.

     

    Item 9.01 Financial Statements and Exhibits

    (d) Exhibits

    The following exhibits are provided as part of the information furnished under Item 2.02 of this Current Report on Form 8-K:

     

     

     

    99.1

    NOV Inc. press release dated April 28, 2025 announcing the earnings results for the quarter ended March 31, 2025.

     

     

     

    99.2

     

    Presentation Materials dated April 29, 2025.

     

     

     

    104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: April 29, 2025

     

    NOV INC.

     

     

     

     

     

    /s/ Peter F. Vranderic

     

     

    Peter F. Vranderic

     

     

    Vice President

     


    Get the next $NOV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NOV

    DatePrice TargetRatingAnalyst
    3/24/2025$22.00Sector Perform → Outperform
    RBC Capital Mkts
    1/15/2025$25.00 → $18.00Outperform → In-line
    Evercore ISI
    1/6/2025Buy → Neutral
    Seaport Research Partners
    12/19/2024$17.00Neutral
    Piper Sandler
    11/11/2024$21.00 → $18.00Buy → Neutral
    Citigroup
    10/28/2024$28.00 → $22.00Buy
    TD Cowen
    9/25/2024$20.00 → $16.00Equal Weight → Underweight
    Wells Fargo
    7/29/2024$27.00 → $28.00Buy
    TD Cowen
    More analyst ratings